E-DRUG: Valeant subpoenaed by US prosecutors over drug pricing
-------------------------------------------------------------------------
[This is an important article that really highlights the irrationality of drug pricing}
US | Thu Oct 15, 2015 9:02am EDT
Valeant subpoenaed by US prosecutors over drug pricing
BY NATALIE GROVER
Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N), under fire for price increases of its two heart drugs, said it was subpoenaed by U.S. prosecutors on its pricing, drug distribution and patient assistance programs.
Valeant's U.S.-listed shares were down 9 percent at $156.53 in premarket trading on Thursday.
The company, which came under attack from Democratic lawmakers in late September over "massive" price increases, said it was reviewing subpoenas from the offices of attorneys for the District of Massachusetts and the Southern District of New York.
Valeant intends to cooperate with the investigations, the company said late on Wednesday.
Read the whole article at the link provided here:
Kind regards
Lucas F.M. van der Hoeven
Ph-D student EU-policy with regard on benzodiazepines
Heuvel 20
5101 TD Dongen (N-B)
The Netherlands / Europe
Lucas <lucas.van.der.hoeven@cbsm.nl>